Research
OSOPIA® is a synthetic Biphasic Calcium Phosphate (BCP) manufactured using an innovative proprietary process that creates a unique active surface on the graft. It is mineralized like FDBA and has a unique 3DI surface that closely mimics the properties of DFDBA. Therefore it resembles a mix of FDBA and DFDBA without the problematic safety and ethical issues of using allograft bone.
Slow resorption profile providing continuous remodeling process for 100% vital bone. Resorption times closely mimics traditional allograft time frames and can be used in similar indications.
3DI (three-dimensional integrated) microarchitecture is an excellent surface for osteoblast activity. Osopia’s unique micropore size between 0.3 and 1.1 microns results in better bone formation in extraction sockets or sinuses.
Synthetic graft concept designed for maximum product safety and performance. Socially conscious raw materials and no risk of disease transmission.
OSOPIA can be used in following indications: